The American Academy of Allergy, Asthma & Immunology (AAAAI) is the largest professional medical organization in the United States dedicated to the allergy/immunology specialty. Founded in 1943, the AAAAI represents asthma specialists, clinical immunologists, allied health professionals, and others with a special interest in the research and treatment of allergic disease. With more than 6,500 members in the United States, Canada, and 72 other countries, the AAAAI is devoted to advancing the knowledge and practice of allergy, asthma, and immunology for optimal patient care. As a Health Care industry player, AAAAI's mission aligns with the growing need for specialized medical expertise in the field of allergy and immunology, reflecting the increasing prevalence of these conditions. While details on recent investments and investors are not available, the organization's longstanding presence and extensive membership network position it as a potentially lucrative investment opportunity, particularly given the rising demand for specialized healthcare services. Located in the United States, AAAAI's strategic positioning in a leading global healthcare market further enhances its investment potential.
There is no investment information
No recent news or press coverage available for American Academy of Allergy, Asthma and Immunology - AAAAI.